(Photo : Photo by Paula Bronstein/Getty Images)
A chicken peers out from a cage at the Sanoh chicken farm January 27, 2007 in Suphanburi, Thailand. The family run Sanoh farm has around 5,000 chickens located in one of the main chicken farm areas two hours north of Bangkok. Although the farm has been completely free of Bird Flu, its owners say that they are struggling to make ends meet with lower prices on eggs and increased prices on chicken feed.
According to The New York Times latest report, the medical innovation is the first vaccine that uses a new molecular design. This new technology could allow NDV-HXP-S to produce more potent antibodies than the current COVID-19 medicines such as Sinovac, Moderna, Johnsons and Johnsons, and more.
Covid-19: North Korea, Citing Pandemic, Will Skip Tokyo Summer Olympics
nytimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nytimes.com Daily Mail and Mail on Sunday newspapers.
Экс-губернатор Пензенской области останется в СИЗО до 20 мая | Пензенская область
fedpress.ru - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fedpress.ru Daily Mail and Mail on Sunday newspapers.
Researchers Are Hatching a Low-Cost Coronavirus Vaccine
A new formulation entering clinical trials in Brazil, Mexico, Thailand and Vietnam could change how the world fights the pandemic.
A vaccination drive in Bangkok in March. Countries struggling to obtain vaccines from wealthier countries may be able to make NVD-HXP-S for themselves or acquire it at low cost from neighbors.Credit.Adam Dean for The New York Times
April 5, 2021, 5:00 a.m. ET
A new vaccine for Covid-19 that is entering clinical trials in Brazil, Mexico, Thailand and Vietnam could change how the world fights the pandemic. The vaccine, called NVD-HXP-S, is the first in clinical trials to use a new molecular design that is widely expected to create more potent antibodies than the current generation of vaccines. And the new vaccine could be far easier to make.